👉 Today, nearly 90% of clinical trials fail, with half due to lack of efficacy. One of the main reasons? Animal models often fail to accurately reflect human biology, slowing down innovation and delaying patient access to life-saving treatments.

💙 To tackle this challenge, we’re proud to welcome NETRI 🇫🇷 to the 3DEXPERIENCE Lab program 🎉. Led by Thibault Honegger, this startup is transforming preclinical research with its unique methodology, “Neurons as a Sensor.” Using its proprietary device, NeoBento (a standardized 96-well platform), the company isolates the nervous system and captures digital signatures of how drugs interact with human cells.

These signatures are analyzed using artificial intelligence and compared to a growing reference library, enabling researchers to predict efficacy and toxicity before human trials even begin.

🎯 Mission: Reduce clinical trial failures - Accelerate time-to-patient - Enable safer, more reliable, and ultimately personalized treatments